Automating Specialty Drug Prior Auth in New Hampshire

Navigating specialty drug prior auth in New Hampshire requires a robust, integrated approach to manage the complexities of high-cost therapies across diverse payer landscapes. Klivira provides the automation needed to accelerate patient access and optimize revenue cycles.

For revenue cycle directors, prior authorization coordinators, and IT integration leads in New Hampshire, managing specialty drug prior authorizations presents unique challenges. The interplay of state-specific Medicaid managed care plans, varied commercial payer footprints, and the inherent complexity of biologics and high-cost therapies demands a sophisticated automation strategy. Ensuring timely access to these critical medications while minimizing administrative burden is paramount for patient care and financial health.

The Challenge of Specialty Drug Prior Auth in New Hampshire

Specialty drugs, encompassing biologics, biosimilars, and complex injectables, often fall under either the medical or pharmacy benefit, complicating prior authorization workflows. In New Hampshire, healthcare providers must contend with a landscape where benefit-side determination, site-of-care policies, and step-therapy requirements vary significantly across different payers. This fragmentation frequently leads to misclassifications, submission delays, and increased denial rates, impacting both patient outcomes and clinic profitability.

Common Pain Points in Specialty Drug PA Workflows

**Benefit-side misclassification**: Incorrectly routing a specialty drug PA to the medical instead of pharmacy benefit, or vice-versa, causing rework and delays.
**Complex documentation**: Gathering extensive clinical data, including prior-line therapy history and specific J-codes or HCPCS codes, for medical benefit submissions.
**Site-of-care policy enforcement**: Navigating payer-specific policies that steer medical-benefit specialty drug administration toward lower-cost sites like infusion centers.
**Payer portal fragmentation**: Manually accessing numerous payer portals for medical PA, or navigating various ePA platforms like CoverMyMeds and Surescripts for pharmacy benefits.
**Specialty pharmacy coordination**: Delays in post-approval fulfillment due to inefficient handoffs to specialty pharmacy partners like Accredo or CVS Specialty.

Klivira's Automated Solution for Specialty Drug PA in New Hampshire

Klivira's platform provides an end-to-end automation solution for specialty drug prior authorization, designed to address the specific complexities encountered in New Hampshire's healthcare environment. By integrating with existing EMRs and leveraging advanced policy engines, Klivira streamlines the entire PA process from prescription to approval, ensuring compliance with payer requirements and accelerating patient access to vital therapies.

Key Automation Capabilities for Specialty Drug PA

**Automated Benefit-Side Determination**: Klivira's engine intelligently identifies whether a specialty drug falls under the medical or pharmacy benefit for each specific payer and patient context, eliminating misclassification errors.
**Multi-Channel PA Routing**: Pharmacy-benefit specialty drugs are routed efficiently through NCPDP SCRIPT ePA via partners like CoverMyMeds and Surescripts. Medical-benefit drugs utilize channels such as X12 278, Da Vinci PAS, and direct provider portal integration.
**Clinical Documentation Automation**: The platform extracts medication history and treatment response data from FHIR MedicationRequest and Observation resources to automatically populate step-therapy and prior-line therapy documentation.
**Site-of-Care Policy Adherence**: Klivira incorporates payer site-of-care logic, surfacing requirements for alternative administration sites before submission to prevent denials.
**Specialty Pharmacy Fulfillment Coordination**: Post-approval, Klivira coordinates the handoff to specialty pharmacy partners, streamlining the fulfillment workflow and reducing time-to-medication.

Technical Standards for Efficient Specialty Drug PA

Adherence to industry standards is critical for robust prior authorization automation. Klivira leverages key technical standards to ensure seamless data exchange and interoperability. This includes NCPDP SCRIPT for pharmacy ePA, FHIR for clinical data exchange, Da Vinci PAS for medical-benefit PAS-conformant submissions, and X12 278 for traditional EDI medical-benefit submissions. These standards facilitate a more connected and efficient PA ecosystem, reducing manual effort and improving data accuracy.

Frequently asked questions

How does Klivira handle the medical vs. pharmacy benefit split for specialty drugs?

Klivira employs an intelligent policy engine that automatically determines the correct benefit side (medical or pharmacy) for each specialty drug, considering the specific payer and patient context. This prevents common misclassification errors and ensures the PA request is routed through the appropriate channel from the outset.

Does Klivira integrate with existing EMRs for specialty drug PA data?

Yes, Klivira integrates with EMRs to extract essential clinical data, such as medication history and treatment response, using FHIR MedicationRequest and Observation resources. This automation populates step-therapy and prior-line therapy documentation, significantly reducing manual data entry and potential errors.

How does Klivira address site-of-care requirements for medical-benefit specialty drugs?

Klivira's platform incorporates payer-specific site-of-care policies into its submission logic. It identifies and flags situations where a payer requires an alternative administration site (e.g., infusion center instead of hospital outpatient department) before the PA is submitted, helping to prevent denials.

Can Klivira help with specialty pharmacy fulfillment after PA approval?

While Klivira does not directly manage drug dispensing, it coordinates the post-approval handoff to the payer's specialty pharmacy partners. This streamlined workflow helps reduce delays in fulfillment scheduling, ensuring patients receive their approved specialty medications more quickly.

What industry standards does Klivira support for specialty drug prior authorization?

Klivira supports key industry standards including NCPDP SCRIPT for pharmacy ePA, FHIR for clinical data exchange, Da Vinci PAS for medical-benefit PAS-conformant submissions, and X12 278 for EDI medical-benefit submissions. This multi-standard approach ensures comprehensive connectivity across diverse payer and PBM systems.